Plasmodium vivax causes approximately 100 million clinical malaria cases yearly 1,2 . The basis of protective immunity is poorly understood and thought to be mediated by antibodies 3,4 . Cytotoxic CD8 + T cells protect against other intracellular parasites by detecting parasite peptides presented by human leukocyte antigen class I on host cells. Cytotoxic CD8 + T cells kill parasite-infected mammalian cells and intracellular parasites by releasing their cytotoxic granules 5,6 . Perforin delivers the antimicrobial peptide granulysin and death-inducing granzymes into the host cell, and granulysin then delivers granzymes into the parasite. Cytotoxic CD8 + T cells were thought to have no role against Plasmodium spp. blood stages because red blood cells generally do not express human leukocyte antigen class I 7 . However, P. vivax infects reticulocytes that retain the protein translation machinery. Here we show that P. vivax-infected reticulocytes express human leukocyte antigen class I. Infected patient circulating CD8 + T cells highly express cytotoxic proteins and recognize and form immunological synapses with P. vivax-infected reticulocytes in a human leukocyte antigen-dependent manner, releasing their cytotoxic granules to kill both host cell and intracellular parasite, preventing reinvasion. P. vivax-infected reticulocytes and parasite killing is perforin independent, but depends on granulysin, which generally efficiently forms pores only in microbial membranes 8 . We find that P. vivax depletes cholesterol from the P. vivax-infected reticulocyte cell membrane, rendering it granulysin-susceptible. This unexpected T cell defense might be mobilized to improve P. vivax vaccine efficacy.
Although CD8 + T cells were not expected to recognize the blood-stage parasite, we analyzed activation markers on circulating CD8 + CD3 + T cells from uncomplicated P. vivax malaria patients by flow cytometry (Fig. 1a,b ). These cells were primarily conventional T cell antigen receptor α β (TCRα β ) CD8 + T lymphocytes ( Supplementary Fig. 1a,b ). Although the abundance of circulating CD8 + T cells and other lymphocytes (natural killer (NK), γ δ T cells, natural killer T (NKT) cells) that might contribute to malaria immune defense did not differ in patients and healthy donors (HDs) from the same endemic region of Brazil ( Supplementary Fig. 1c,d) , CD8 + T cells from untreated patients had increased expression of CD69 and human leukocyte antigen D-related (HLA-DR) activation markers and Ki67, a cell proliferation indicator. These markers returned to levels similar to those in HDs 30-40 days after treatment with chloroquine and primaquine and parasitological cure. Circulating CD8 + T cell expression of cytotoxic granule granzyme B (GzmB), perforin (PFN) and granulysin (GNLY) was also considerably increased in malaria patients compared with HDs from the endemic area ( Fig. 1c,d) . These results confirm studies suggesting that circulating CD8 + T cells are activated during P. vivax, and to a lesser extent P. falciparum, infection [18] [19] [20] [21] [22] . Acute patient plasma also contained ~6-fold more GNLY than HD plasma by ELISA ( Fig. 1e ). To identify the source of GNLY, we analyzed innate, innate-like and conventional α β T cells from HDs and acute malaria patients for GNLY expression ( Supplementary Fig. 1e ). Most GNLY + circulating lymphocytes in patients were conventional CD8 + T cells (69.7% ± 1.2%). A higher proportion of GNLY + circulating lymphocytes were conventional CD8 + T cells in patients than HDs (P = 0.03). Fewer than 10% of the circulating GNLY + cells were CD4 + T cells, γ δ T cells, NK cells, or NKT cells in either patients or HDs. Thus, conventional CD8 + T cells express most of the GNLY in infected patients.
On the basis of these data, we hypothesized that CD8 + T cells in patients with P. vivax malaria might become activated by recognizing P. vivax-infected reticulocytes (iRetics), causing them to degranulate and release GNLY. Although P. falciparum infects mature red blood cells (RBCs), asexual P. vivax exclusively infects Retics, which retain the translation machinery, endoplasmic reticulum and Golgi apparatus needed to produce cell surface proteins. An early electron microscopy study suggested that human Retics weakly express human leukocyte antigen class I (HLA-I) 7 . More recent transcriptome and proteome analyses indicated that Retics express HLA and Letters NaTure MeDICINe proteins involved in antigen presentation 23, 24 , including the proteasome, TAP transporter and cofactor TAPASIN, and the endoplasmic reticulum aminopeptidase ERAP1 ( Supplementary Table S1 ). We therefore used a pan − class I antibody to compare HLA-I expression on the surface of uninfected and iRetics from patients and HDs. iRetics were identified by SYBR Green I staining 25 , which stains parasite DNA, but not Retic RNA ( Supplementary Fig. 2 ). RBCs were gated based on size and granularity and CD235a (glycophorin A) staining ( Fig. 2a) , and Retics were identified as CD235a + and CD71 + (transferrin receptor). As expected 26 , acute malaria patient 0 10 3 10 4 10 5 0 10 3 10 4 10 5 0 10 3 10 4 10 5 0 10 3 -10 3 10 4 10 5 0 10 3 -10 3 10 4 10 5 0 1 0 3 -10 3 10 4 10 5 0 10 3 -10 3 10 4 10 5 0 1 0 3 -10 3 10 4 10 5 0 1 0 3 -10 3 10 4 10 5 0 10 3 10 4 10 5 0 10 3 10 4 10 5 -10 2 PBMCs from HDs and P. vivax malaria patients (Pv) were gated on CD8 + CD3 + T cells (gating strategy described in Supplementary Fig. S1 ) and analyzed for expression of activation markers and cytotoxic granule proteins by flow cytometry. a,b, Shown are representative flow plots (a) and the proportion of malaria patients' CD8 + T cells expressing CD69, HLA-DR and Ki67 (b) before treatment (BT) and 30-40 days after treatment and parasitological cure (AT). n = 8 biologically independent samples/independent experiments. Statistical analysis was performed by two-tailed parametric paired t-test at 95% CI. c,d, Shown are representative flow plots (c) and the proportion of HD and Pv peripheral blood CD8 + T cells expressing GzmB, PFN, and GNLY (d) BT. n = 5 biologically independent samples/independent experiments. e, The levels of soluble GNLY in plasma of n = 7 HD and n = 10 Pv BT were measured by ELISA as biologically independent samples/ independent experiments. In d,e, mean ± s.e.m. is shown; statistical analysis was performed by two-tailed nonparametric unpaired t-test at 95% CI. i, Immunoblot of cell lysates from three HD uRetics and three Pv iRetics, loaded with 50 μ g of protein/well and probed for the antigen processing protein, TAP1, as well as β -actin and F-actin as loading controls for HD uRetics and Pv BT iRetics, respectively. HD PBMCs were used as a positive control (20 μ g). This experiment was repeated three times with similar results.
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RBCs contained ~5-fold more Retics than HDs (Fig. 2b ). About half of patient Retics stained for HLA-I, compared with ~10% in HDs (P < 0.0001) ( Fig. 2c ). Of circulating Retics from patients, 50.3% ± 7.0% were infected (Fig. 2d ), and 57.1% ± 7.9% of iRetics expressed HLA-I at levels comparable with that on B lymphocytes ( Fig. 2e ,f) but did not express HLA-DR ( Fig. 2g ). In contrast, < 20% of uninfected SYBR Green − Retics from patients expressed HLA-I (P < 0.0001). Imaging flow cytometry confirmed HLA-I expression selectively on iRetics, compared with HD Retics (Fig. 2h ). Cell surface HLA expression depends on antigenic peptide binding 27 . To confirm that iRetics have the antigen processing machinery, we used density separation to isolate iRetics from Letters NaTure MeDICINe three infected donors and uninfected Retics (uRetics) from three HDs ( Supplementary Fig. 3a,b ), and analyzed their expression of TAP1 by immunoblot. TAP1 was readily detected in iRetics, but not uRetics ( Fig. 2i ). Thus, iRetics selectively express HLA-I and TAP1, suggesting they might present malaria antigens to CD8 + T cells. Long-term P. vivax culture has not been possible, limiting studies of the immune response to blood-stage infection. We developed a short-term in vitro culture system 19, 28, 29 that enabled us to study the CD8 + T cell response to iRetics. CD8 + T cells, isolated by immunomagnetic selection from HDs or patients, were cultured for 10 h with autologous, enriched uRetics or iRetics, respectively ( Supplementary Fig. 3c ). iRetic incubation activated infected donor CD8 + T cells to express CD69 and Ki67 and produce IFN-γ ( Fig. 3a-c) . In contrast, HD CD8 + T cells did not respond to uRetics. αHLA-ABC αHLA-ABC αHLA-ABC Isotype Isotype Isotype iRetics αCD3αCD28
Fig. 3 | CD8 + T cells are activated by and lyse autologous P. vivax-infected reticulocytes. a-d,
Purified CD8 + or CD4 + T lymphocytes from HDs or patients with P. vivax malaria (Pv) before treatment (BT) were cultured in medium alone, with autologous uRetics, with purified iRetics, or in the presence of anti-CD3 and anti-CD28, and analyzed by flow cytometry for the proportion of CD8 + T cells staining for CD69 (a) and Ki67 (b) (n = 5) or intracellular IFN-γ (c) (n = 8), or CD4 + T cells staining for intracellular IFN-γ (d) (n = 6). e, IFN-γ expression by CD8 + T cells after stimulation with autologous uninfected RBCs (uRBC), purified iRetics, or anti-CD3 and anti-CD28 in the presence of anti-HLA-ABC or isotype control antibody (n = 6). f,g, Imaging flow cytometry analysis of immune synapse formation between CD8 + T cells and autologous purified iRetics from Pv or uRetics from HDs (n = 5). Shown are representative images of immunological synapses between CD8 + T cells and purified iRetics from a Pv sample, arrow indicates immunological synapse, i.e., overlay staining of anti-TCR, anti-CD3, anti-HLA-ABC and anti-CD8 labeled antibodies (f) and mean ± s.e.m. of the proportion of CD8 + T cells forming synapses in five HD samples with autologous uRetics and in five Pv BT samples with purified iRetics (g). n = 5 biologically independent samples/independent experiments. Cells were stained for TCR and CD235a, CD3, HLA-ABC, and CD8, and synapses were identified by the capping and colocalization of TCR, CD3, CD8, and HLA-ABC where the T cell and RBC are juxtaposed. The enlarged overlay image on the right corresponds to the bottom image. h,i, Survival of iRetics after 12-h incubation with medium or autologous CD8 + T cells from Pv samples (n = 5) (h) or of uRetics incubated with medium or autologous HD CD8 + T cells (n = 4) (i), added at indicated E:T ratios, as assayed using CFSE-labeled Retics. j, iRetic lysis after 12-h incubation with medium or autologous CD8 + T cells from Pv samples (n = 8), measured by LDH release. k, Frequency of CD8 + T cells in the blood of five untreated Pv that degranulate, assessed by CD107a staining, in response to indicated stimuli. Shown are mean ± s.e.m.; statistical analysis by nonparametric two-way ANOVA (a-e), two-tailed nonparametric unpaired t-test at 95% CI (g), and nonparametric one-way ANOVA (h-k).
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Both patient and HD CD8 + T cells were activated by anti-CD3/anti-CD28. Neither patient nor HD CD4 + T cells responded to iRetics ( Fig. 3d ). Importantly, HLA-I blocking, but not control, antibody 30 prevented iRetic-induced IFN-γ production by CD8 + T cells, but did not affect anti-CD3/anti-CD28 activation, which does not require HLA-I ( Fig. 3e ). Thus, circulating CD8 + T cells in infected patients specifically recognize HLA-I-bound antigens on iRetics. Imaging flow cytometry was next used to visualize the CD8 + T cell-iRetic interaction, by staining cocultures for HLA-I, CD235a, CD3, CD8 and TCR ( Fig. 3f,g) . Of circulating CD8 + T cells from five malaria donors, 10.9% ± 2.2% formed immune synapses in which TCR, CD3 and CD8 on the T cell capped and colocalized with HLA-I on autologous iRetics. By contrast, < 1% of HD CD8 + T cells formed synapses with autologous Retics. To examine whether CD8 + T cells lyse iRetics, we cocultured carboxyfluorescein diacetate succinimidyl ester (CFSE)-stained infected donor or HD Retics at different ratios with autologous CD8 + T cells, and assessed by flow cytometry the persistence of CFSE-stained cells 12 h later ( Fig. 3h,i) . Infected donor CD8 + T cells considerably reduced the number of iRetics, but HD CD8 + T cells did not affect uRetics, indicating the specificity of iRetic lysis in infected patients. iRetic lysis by autologous patient CD8 + T cells was confirmed by measuring lactate dehydrogenase (LDH) release that increased with more CD8 + T cells ( Fig. 3j ). Activated CD8 + T cells kill infected cells by cytotoxic granule exocytosis, which can be measured by externalization of LAMP-1 (CD107a). After incubation with autologous iRetics, but not uninfected RBCs, infected donor CD8 + T cells stained for surface CD107a, indicating that they degranulated ( Fig. 3k ). Moreover, the numbers of CD107a + CD8 + T cells after iRetic coculture were not considerably different from the numbers that degranulated after anti-CD3/anti-CD28 treatment, suggesting that most of the circulating activated CD8 + CTLs in infected donors specifically recognize iRetics.
CTLs kill other intracellular parasites in a PFN-, GNLY-, and Gzm-dependent manner 5 . To determine how iRetics are lysed and whether P. vivax are killed in the process, we first used imaging flow cytometry to determine whether Alexa Flour 488 (AF488)-labeled GNLY and/or GzmB bound and/or entered uRetics or iRetics ( Fig. 4a-f ). GNLY, but not GzmB on its own, selectively bound to iRetics, but not uRetics ( Fig. 4a-d ). Moreover, when GNLY was present, virtually all iRetics, but not uRetics, stained with GzmB ( Fig. 4e,f ). GNLY colocalized with CD235a on the iRetic membrane, whereas GzmB was internalized and colocalized with intracellular P. vivax, stained with a Hoechst DNA dye ( Fig. 4g , Supplementary  Fig. 4 ). In some iRetics, GzmB also showed punctate host cell staining, which might represent GzmB trafficking to host mitochondria, where Gzms concentrate 31 . Thus, GNLY, independently of PFN, delivers GzmB to the parasite, a surprising finding, because in other intracellular parasite infections, PFN is required to deliver GNLY and Gzms across host cell membranes 5 .
GNLY permeabilizes cholesterol-containing mammalian cell membranes only at exceedingly high (micromolar) concentrations, because cholesterol inhibits pore formation 8 . In contrast, PFN is a cholesterol-dependent cytolysin. Other Plasmodium species harvest and deplete cholesterol from RBC membranes 32, 33 , which could make them susceptible to GNLY. When we depleted cholesterol from RBC membranes using methyl-β -cyclodextrin, AF488-labeled GNLY attached to the cholesterol-depleted, but not to untreated, RBC membranes ( Fig. 4h ), delivered GzmB-AF488 into the RBCs (Fig. 4i) , and lysed cholesterol-depleted RBCs (Fig. 4j ). To determine whether cholesterol was depleted from iRetic membranes, we stained Retics with 25-[N-[(7-nitro-2-1,3benzoxadiazol-4-yl)methyl]amino]-27-norcholesterol (25-NBDcholesterol), a fluorescent cholesterol mimic. iRetics, but not uRetics, stained brightly with 25-NBD-cholesterol ( Fig. 4k,l) , suggesting that P. vivax also harvests cholesterol from iRetic membranes, making them GNLY-susceptible.
GNLY-delivered GzmB colocalization with the parasite (Fig. 4g ) suggested that GNLY and GzmB would not only lyse iRetics, but might also directly kill the parasite. To determine which cytotoxic molecules are required to lyse iRetics and whether intracellular parasites are also killed, we incubated GNLY, GzmB, and/or PFN with iRetics ( Fig. 4m ) or HD uRetics ( Fig. 4n ) for 1 h and measured RBC lysis by LDH release and parasite viability by the ability to invade fresh Retics 34 (Fig. 4o ). GNLY on its own lysed iRetics, but GzmB or PFN, alone or together, had no substantial effect. However, GNLY and GzmB were considerably more cytotoxic than GNLY, and GzmB, GNLY, and PFN further substantially enhanced iRetic lysis. Importantly, uRetics were unaffected by GzmB or GNLY, but were lysed by PFN, as expected, because their membranes are cholesterol rich. GNLY alone inhibited parasite invasion of fresh RBCs, but GNLY and GzmB together or all three cytotoxic molecules completely blocked reinvasion. Reinvasion could be inhibited because of parasite killing or because parasite maturation or infectious merozoite release was hindered. To determine whether the parasites within iRetics were directly damaged, we analyzed iRetic morphology by electron microscopy after treatment with GNLY ± GzmB (Fig. 4o ). After just GNLY, the treated iRetics swelled and the intracellular parasites started to show signs of death, such as cytoplasmic vacuolization, consistent with iRetic membrane damage by GNLY. However, after incubation with both GNLY and GzmB, intracellular parasites developed swollen and fragmented mitochondria, condensed nuclei, and cytoplasmic vacuolization, and the parasitophorous vacuole membrane was disrupted (Fig. 4p) . These changes resembled morphological changes seen after GzmB and GNLY treatment of other protozoan parasites 5 . The protocol used 
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to select iRetics enriches for trophozoite-stage infection. Thus, GNLY and GzmB not only lyse iRetics, but also directly kill intracellular trophozoites and block reinvasion.
In conclusion, P. vivax iRetics highly express HLA-I and are specifically recognized by CD8 + T cells. This is, to our knowledge, a unique example of CD8 + T cells recognizing Retics in an HLArestricted antigen-specific manner. Because GNLY on its own delivers GzmB into iRetics, the CTL mechanism that lyses iRetics is distinct from granule-mediated killing of other mammalian target cells and intracellular parasites, which requires PFN. iRetic lysis would be expected to reduce parasite infectivity by releasing parasites that have not yet matured to the infectious merozoite stage from their obligate intracellular niche. However, here we provide evidence that CD8 + T cells also directly kill P. vivax, which should enhance immune effectiveness by limiting spreading of infectious organisms. Whereas patient CTLs lysed iRetics in a 12-h assay, parasite killing and inhibition of reinvasion occurred within an hour of adding GNLY and GzmB, suggesting that parasite death is rapid. The molecular mechanism of P. vivax killing remains to be defined, which will be challenging without long-term culture systems for P. vivax. Nevertheless, our findings identify a previously unsuspected protective mechanism against blood-stage parasites and suggest that a vaccine that elicits CTLs against bloodstage P. vivax may help prevent transmission and control disease Letters NaTure MeDICINe severity. In the future, it will be worthwhile to examine whether other innate or innate-like killer lymphocytes that express GNLY, such as NK and γ δ T cells, recognize and kill iRetic and play a role in immune protection [35] [36] [37] [38] [39] . Future studies are also needed to determine whether killer lymphocytes are always beneficial during blood-stage malaria, because they might contribute to anemia, inflammation or other pathological sequelae of infection.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41591-018-0117-4. Reagents. All antibodies and fluorescent dyes used in our experiments are listed in Supplementary Table S2 .
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Sample preparation. Peripheral blood mononuclear cells (PBMCs), obtained by Ficoll (GE Healthcare) gradient centrifugation as previously described 40 , were stained for CD69, Ki67, HLA-DR, PFN, GNLY and GzmB. CD8 + and CD4 + T cells were purified from PBMCs by positive selection using Dynabeads (Thermo Fisher Scientific). The RBC pellet, suspended in isotonic Percoll, was used to purify iRetics from malaria patient samples on a 45% isotonic Percoll (GE Healthcare) gradient and uRetics from HDs on 70% Percoll. Uninfected erythrocytes (uRBCs) were obtained from the Percoll gradient pellet.
T lymphocyte and RBC coculture. Purified T cells (10 5 /well) and Retics (5 × 10 5 /well) were cocultured at 37 °C for 10 h in 96-well plates to assess T cell activation, IFN-γ production and degranulation (CD107a) 41 . Some experiments were performed in the presence of 2 μ g/ml HLA-ABC blocking antibody (W6/33) or isotype control, which were added to CD8 + T cells 30 min before RBC coculture. T lymphocytes cultured with 1 μ g/ml anti-CD3 (BD Pharmingen) and 0.5 μ g/ml anti-CD28 (BD Pharmingen) were used as positive controls. Proteomic and transcriptomic analysis. Databases for the Retic proteome 23 and transcriptome 24 were analyzed for expression of proteins involved in the endogenous antigen presentation pathway ( Supplementary Table S1 ) using ID_REF data deposited in the Gene Expression Omnibus (http://www.ncbi.nlm. nih.gov/geo/) (accession numbers: GSM143572-143599, GSM143671-143682, GSM143703, GSM143706-143716, GSM143718-143721).
Cytotoxic enzymes. GzmB, GNLY and PFN were purified from YT-Indy cells as described previously 47 . Purity was > 95%, as determined by Coomassie-stained SDS-polyacrylamide gel electrophoresis. Protein concentrations were determined by Bradford assay. Specific activity of GNLY and PFN was determined by serial dilution on iRetics and uRetics; a sublytic concentration (< 20% killing, adequate to deliver Gzms, but not kill most host cells) was used in all experiments. Specific activity of GzmB was determined by cleavage of the peptide substrate, t-Butyloxycarbonyl-Ala-Ala-Asp-ThioBenzyl ester, in the presence of 5,5′ Dithiobis (2-nitrobenzoic acid).
Reticulocyte lysis assay. iRetics labeled with CFSE (Sigma-Aldrich) were cultured with CD8 + T cells at indicated ratios. Twelve hours later, cells were harvested and stained for CD235a and CD8. The number of surviving CFSE + gated CD235a + cells was compared with the number of CFSE + cells surviving after culture in the absence of lymphocytes. LDH release, measured by CytoTox 96 (Promega), was used to assess RBC lysis after coculture for 12 h with CD8 + T cells at indicated Effector:Target (E:T) ratios. To assess cytolysis by purified granule proteins, we incubated iRetics for 1 h at 37 °C with 100 nM GNLY ± 500 nM GzmB ± a sublytic concentration of PFN and analyzed the culture supernatants by LDH release assay. The morphology of treated Retics was assessed by electron microscopy.
Parasite invasion assay. Invasion assays were performed as previously described 34 . iRetics from patients with P. vivax malaria, enriched on a 45% Percoll gradient, were treated with 100 nM GNLY ± 500 nM GzmB ± a sublytic concentration of PFN for 1 h at 37 °C. Uninfected HD reticulocytes, obtained from a 70% Percoll gradient, were added to the washed, treated iRetics at a ratio of 10:1. After 24-h coculture, cytospins were stained with Giemsa, and the proportion of newly invaded ring-stage-infected cells was enumerated.
Imaging flow cytometry. Purified CD8 + T cells and Retics were cocultured at an E:T ratio of 1:5 for 1 h and then stained with HLA-ABC, TCR, CD3, CD8 and CD235a antibodies before analysis on an ImageStream Amnis X using Ideas software (Amnis). CD235a + CD3 + doublets were selected based on aspect ratio versus cell area. Purified iRetics and uRetics were incubated with 100 nM GNLY-AF488 or 500 nM GzmB-AF488 in the presence or absence of 100 nM unlabeled GNLY for 1 h at 37 °C as described previously 5 . Cells were washed and fixed with 2% paraformaldehyde in PBS before imaging flow cytometry. The frequency of cells staining for GNLY and GzmB was quantified using Ideas software. To analyze colocalization, we stained images of iRetics incubated for 1 h with 100 nM GNLY-AF647 and 500 nM GzmB-AF488 with CD235a-PE and Hoechst 33342.
Cholesterol depletion. HD RBCs in Hank's Balanced Salt Solution were untreated or incubated with indicated concentrations of methyl-β -cyclodextrin for 30 min at 37 °C before adding indicated amounts of purified GNLY and GzmB or GzmB-AF488 and culturing for 1 h. Treated cells were analyzed by flow cytometry for GNLY and GzmB uptake by flow cytometry or for LDH release as described earlier.
Electron microscopy. Purified iRetics incubated with 100 nM GNLY ± 500 nM GzmB were fixed in 2.5% buffered glutaraldehyde solution, 0.1 M (pH 7.2), for 3 h at 4 °C, washed, and the cell pellet was immersed in 4% agarose. The pellet was fixed in 1% osmium tetroxide and 1.5% (w/v) potassium ferrocyanide, dehydrated in ethanol, and embedded in Araldite 502 (Electron Microscopy Sciences). Extra-thin sections, obtained using a Sorvall MT-2B ultramicrotome (Dupont), were applied to 200-mesh copper grids (Ted Pella) and stained with 2% uranyl acetate and Reynolds' lead citrate. Images were obtained by transmission electron microscopy using a Tecnai G2-12 Spirit BioTWIN 120 kV (FEI).
Statistical analysis.
Statistical analysis was performed using GraphPad Prism V7.0. Before applying statistical methods, whether the data fit a normal distribution was evaluated by the D' Agostino and Pearson normality test. The distribution was considered normal when P ≤ 0.05. Parametric or nonparametric (Mann-Whitney test) two-tailed paired and unpaired t-tests were used to compare two groups at 95% confidence interval (CI Our study was planned to enroll 30 individuals in each of our patient groups over the course of two years of the study. The hypothesis was that symptomatic malaria patients before treatment (SBT) should be different from symptomatic after treatment (SAT) and healthy donors (HD). Usually one would use a two sample t-test to make this comparison. In general, with n=30 in each group there is 80% power for a difference of 0.6 SD (shift of 0.6 standard deviations) or 90% power for shift of 0.7 SD. Indeed, were analyzed our published results from the same malaria endemic field and found that the differences observed in mean levels of (for example) cytokine or gene expression in the pre and post treatment symptomatic group of individuals with P. vivax was usually larger than this จC on the order of 1 SD difference. This power calculation suggests that given the expected sample size, we are robustly powered to achieve interpretable and meaningful results. The sample size above was establish for ex vivo phenotypic analysis, presented in figures 1 and 2. For each ex vivo phenotypic characterization, the sample size had a minimum of 5 subjects in order to obtain a powerful significance. In addition, the assays were repeated with difference biological samples. The number of subjects was also dependent on the number of patients included in the study at each collection period. The invitro assays in order to elucidate the immunological mechanisms were performed at least with n=4 per individually experiment, being n=3 the minimum required for 80% power. All the in vitro assays were also dependent in the number of subjects included at the collection period. For the Image cytometry analysis, a n=3 was used, since each sample collection generated 50.000 single cell data. For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
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Antibodies
Describe the antibodies used and how they were validated for use in the system under study (i.e. assay and species).
Each antibody and dye was validated as manufacturer instruction, general 1:200 dilution for the antibodies, 1:1000 dilution for LIVE/DEAD and SYBR Green and undiluted for the Retic count regent. Then, the antibodyes and the SYBR Green were titrated in order to obtain the best concentration to employed in our painels. Policy information about studies involving human research participants
Description of human research participants
Describe the covariate-relevant population characteristics of the human research participants.
Patients infected with P. vivax and healthy donors (control group) living at endemic area for malaria in Porto Velho, Rondonia, Brazil, were included in our study. Both male and felamle individuals ranging from 21 to 59 years old with positive smears (higher than 501 parasites/ mmˆ3) and PCR+ were invited to enroll in the study, and after obtaining consent, was collect 100 ml of blood. Inclusion criteria for acute malaria included documented pyrexia (T> 38 ° C) or frank chill history within 48 h before recruitment and two diagnostic tests (thick smear and PCR). Symptomatic and health donor individuals should not have had malaria therapy in the past 6 months. Individuals co-infected with both Pf and Pv, pregnant women, people receiving treatment with immunosuppressive drugs, and individuals with infectious or chronic inflammatory diseases were excluded. The project was developed in collaboration with the group of researchers and physicians from the Research Center for Tropical Medicine of Rondonia (CEPEM) and FIOCRUZ Rondonia, who were in charged to enroll patients into our study. The IRB protocols were approved at Oswaldo Cruz Foundation and National Ethical Council (CAAE: 59902816.7.0000.5091), University of Massachusetts Medical School (11116) and Boston Children Hospital (00005698).
